Table 2.
Patient-reported severity assessment at the different study visits.
| Category | Baseline Total (%) N = 104 |
End of Cycle 1 (%) N = 89 |
End of Cycle 2 (%) N = 24 |
Day 180 N = 32 (30.8) |
|---|---|---|---|---|
| Clear | 0 (0) | 1 (1.1) | 3 (12.5) | 11 (34.4) |
| Almost clear | 0 (0) | 18 (20.7) | 7 (29.2) | 8 (25.0) |
| Mild | 9 (8.7) | 39 (44.8) | 10 (41.7) | 5 (15.6) |
| Moderate | 38 (36.5) | 28 (32.2) | 4 (16.7) | 4 (12.5) |
| Severe | 56 (53.8) | 1 (1.1) | 0 (0) | 4 (12.5) |
| Missing a | 1/104 (1.0) | 2/89 (2.2) | 1/24 b (4.2) | 4 (11.1) |
| Median | 5.0 (4.0–5.0) | 3.0 (3.0–4.0) | 3.0 (2.0–3.0) | 2.0 (1.0–3.3) |
a Missing proportions were calculated by taking the total number of patients who came for that visit. b Patient global assessment was taken from one patient for whom the clinical assessment was missed, but missed from one patient who had a clinical outcome.